Clinical trial
Prospective Epidemiological Study to Expand Knowledge on Efficacy and Safety of a Routine Post-operative Supportive Therapy With the Mistletoe Extract Iscador® Qu Within Oncological Treatment of Pancreatic Cancer Stages UICC II-IV
NCT01448668 is registered in ClinicalTrials.gov with IFAG AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Epidemiological Study to Expand Knowledge on Efficacy and Safety of a Routine Post-operative Supportive Therapy With the Mistletoe Extract Iscador® Qu Within Oncological Treatment of Pancreatic Cancer Stages UICC II-IV
- Lead sponsor
- IFAG AG
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2010
- Completion date
- June 30, 2016
- Enrollment
- 220 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
pancreas cancer